Generation Bio has revealed the development of a novel form of DNA, known as "immune-quiet DNA" (iqDNA), which is derived from its closed-ended DNA (ceDNA). iqDNA has shown cytokine levels and tolerability comparable to mRNA in studies involving mice and primates. This development could lead to more effective genetic medicines. Generation Bio plans to use iqDNA in their treatments, including one for hemophilia A. Their goal is to make genetic medicines that are safe and can help many people. Read more: https://lnkd.in/dbu2ATgS #dna #therapeutics #medicine #drugdiscovery #medicalscience
